COMPASS Pathways Plc American Depository Shares (CMPS) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
COMPASS Pathways Plc American Depository Shares (CMPS) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 87.3% versus a gain of 0.3%. Over five years, PAHC leads with a +73.0% price change compared with -63.7% for CMPS. COMPASS Pathways Plc American Depository Shares is the larger company by market cap ($1.57 billion vs $1.50 billion), about 1.0 times the size.
Phibro Animal Health pays a dividend yielding 1.30%, while COMPASS Pathways Plc American Depository Shares does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMPS | PAHC |
|---|---|---|
| Share price | $11.32 | $37.00 |
| Market cap | $1.57B | $1.50B |
| 1-day change | -3.21% | -1.91% |
| YTD return | +69.42% | +0.96% |
| 1-year return | +87.34% | +0.27% |
| 5-year return | -63.72% | +73.03% |
| P/E ratio (TTM) | — | 15.23 |
| Forward P/E | — | 9.63 |
| EPS (TTM) | $-3.76 | $2.43 |
| Dividend yield | 0.00% | 1.30% |
| Annual dividend | $0.00 | $0.48 |
| 52-week high | $15.87 | $60.08 |
| 52-week low | $4.88 | $28.25 |
| Distance from 52-week high | -28.70% | -38.42% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +109.90% | +18.92% |
| Average volume | 3.04M | 235.16K |
| Shares outstanding | 138.48M | 21.11M |
| Employees | 156 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CMPS has outperformed PAHC by 87.1 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.30% vs 0.00%).
About COMPASS Pathways Plc American Depository Shares
CMPS stock →COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
Health Care · Biotechnology: Pharmaceutical Preparations · 156 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
CMPS vs PAHC FAQ
Which is bigger, COMPASS Pathways Plc American Depository Shares or Phibro Animal Health?
COMPASS Pathways Plc American Depository Shares (CMPS) is larger, with a market capitalization of $1.57B compared with $1.50B for Phibro Animal Health (PAHC).
Which stock has performed better over the past year, CMPS or PAHC?
CMPS returned +87.34% over the past 12 months, compared with +0.27% for PAHC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, COMPASS Pathways Plc American Depository Shares or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.30%, while COMPASS Pathways Plc American Depository Shares does not currently pay a regular dividend.
Are COMPASS Pathways Plc American Depository Shares and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.